Lower C-reactive protein level seen with self-monitoring program

03/8/2013 | PhysiciansBriefing.com

Data on 483 patients with poorly controlled, insulin-naive type 2 diabetes showed those in a structured intervention for self-monitoring of their blood glucose levels attained greater reductions in their level of high-sensitivity C-reactive protein at three, six and 12 months compared with those in the control group. The results appear in Diabetes Care.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD